TABLE 1.
Baseline characteristics of Aboriginal and non-Aboriginal patients
| Characteristic | Aboriginal, n=44 | Non-Aboriginal, n=2570 |
|---|---|---|
| Age, years, median (range) | 44 (25–58) | 47 (18–76) |
| Male, n (%) | 25 (57) | 1784 (69) |
| BMI, kg/m2, median (range) | 28 (22–37) | 27 (16–56) |
| Liver biopsy performed, n (%) | 43 (98) | 2182 (85) |
| Metavir fibrosis stage, n (%)* | ||
| F0 to F2 | 27 (63) | 1320 (60) |
| F3 | 9 (21) | 430 (20) |
| F4 | 5 (12) | 376 (17) |
| Other/unknown | 2 (5) | 56 (3) |
| HCV genotype, n (%) | ||
| 1 | 31 (70) | 1698 (66) |
| 2 | 4 (9) | 286 (11) |
| 3 | 9 (20) | 468 (18) |
| Other | 0 (0) | 118 (5) |
| Serum HCV-RNA level, IU/mL ×103, median (range) | 569 (14.2–11,600) | 733 (0.6–31,100) |
| Treatment naive, n (%) | 30 (68) | 1716 (67) |
| Previously treated, n (%) | 14 (32) | 854 (33) |
*
Only patients who had a liver biopsy were included in the calculation of percentages. BMI Body mass index; HCV Hepatitis C virus